News | News By Subject | News by Disease News By Date | Search News

Diabetes News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Novo Nordisk A/S (NVO) Investors Disappointed as Top Selling Drug Victoza Didn't Do as Well as Expected     6/14/2016
FDA Panel Unanimously Backs Novo Nordisk A/S (NVO)'s Diabetes Combo Drug Ideglira     5/25/2016
FDA Staff Questions Usefulness of Sanofi (SNY)’s Diabetes Drug Combo     5/23/2016
FDA Questions Study Findings, Practicality of Novo Nordisk A/S (NVO)'s Diabetes Drug Ideglira     5/23/2016
Intarcia Touts Large Phase III Trial Diabetes Data, Bags $75 Million     5/6/2016
Embattled Bay Area XOMA  (XOMA) Terminates Gevokizumab Trials     3/14/2016
Johnson & Johnson (JNJ) Hands Over In-House Rival BetaLogics to ViaCyte, Gives Updates on Stem Cell Diabetes Trial     2/4/2016
Theracos Snags $25 Million for Diabetes Drug     1/18/2016
After Months of Rumors, MannKind Corporation (MNKD) and Sanofi (SNY) Terminate Afrezza Deal     1/5/2016
NovaTarg Therapeutics Aims to Reveal First Drug Candidates for Type 2 Diabetes, Kidney Disease in 2016     12/10/2015
Amidst Job Growth and Strong Stocks, Eli Lilly (LLY) Terminates BIL Diabetes Program     12/4/2015
Novo Nordisk A/S (NVO) Breathes New Life into XOMA  (XOMA) with $295 Million Diabetes Pact     12/2/2015
Derma Sciences (DSCI) Exploring Sale After Stopping Development of Its Only Drug     11/13/2015
Derma Sciences (DSCI)'s Phase III Aclerastide Study Terminated Due to Ineffectiveness     11/12/2015
Johnson & Johnson (JNJ) Unit, Hanmi Pharma Ink Diabetes and Obesity Pact Worth $915 Million     11/9/2015

News from Around the Web
Is "When We Eat" As Important As "What We Eat"? King's College London Study     6/22/2016
New Link Discovered Between Diabetes And Alzheimer's Disease, University Of Aberdeen Study     6/21/2016
Gray Matter Changes In Brains Of Teenagers With Type 2 Diabetes, Cincinnati Children's Hospital Medical Center Scientists Reveal     6/15/2016
Stress-Diabetes Link Detailed in Rice University Study     6/8/2016
GI Windows Anastomosis System For Treating Type 2 Diabetes     6/2/2016
West African Genes Lower The Risk Of Obesity In Men, University of Arizona Suggests Study     6/1/2016
A Quick Picture Of Your Eye Could Help Spot Diabetes Sooner     5/23/2016
Key Gene Linked To Diabetes And Down Syndrome Identified, Flinders University Study     5/20/2016
Eating Junk Food Just As Harmful To Kidneys As Diabetes, Anglia Ruskin University Study     5/10/2016
Blood Glucose Monitor Could Benefit Millions Of Diabetics, Swansea University Study     5/10/2016
Diabetes Drug Metformin Acts Differently From Previous Theories, Mayo Clinic Research Suggests     5/6/2016
Lab-On-A-Chip To Measure Glucose In A Single Drop Of Sweat, Hong Kong Polytechnic University Study     5/2/2016
Eating Chocolate Everyday Could Lower Heart Disease And Diabetes Risk, University of Warwick Study     4/29/2016
Fiber Optic Biosensor-Integrated Microfluidic Chip To Detect Glucose Levels, Hong Kong Polytechnic University Study     4/29/2016
Pulsing Skin Patch Could Be A Cheap Way To Say Goodbye To Pain, ActiPatch Reveals     4/26/2016

Press Releases
VM BioPharma Announces First Patient Dosed In Phase 3 Study Of Gene Therapy Candidate, VM202, In Painful Diabetic Peripheral Neuropathy     6/27/2016
Innocoll (INNL) Announces The Completion Of Enrollment In Two Pivotal Phase III Clinical Trials Of COGENZIA For The Treatment Of Diabetic Foot Infections     6/23/2016
Novo Nordisk Canada Inc. (NVO) Release: Faster-Acting Insulin Aspart Showed A Statistically Significant Reduction In Hba(1c) In Type 1 Diabetes And A Comparable HbA(1c) Reduction In Type 2 Diabetes Versus NovoRapid (Insulin Aspart)     6/14/2016
Janssen R&D Release: Canagliflozin Phase 2 Study Demonstrates Glycemic Improvements In Adults With Type 1 Diabetes     6/14/2016
Abbott (ABT) Announces Positive Results From Groundbreaking Study Of FreeStyle Libre System For People With Type 1 Diabetes     6/14/2016
Metagenics Inc. Release: Randomized Clinical Study Shows Ultra Glucose Control In Combination With A Dietary Plan Results In A Significant Reduction In A1C Levels And Body Weight In Overweight And Obese Patients With Type 2 Diabetes     6/14/2016
American Diabetes Association Release: Liraglutide Lowers Risk For Cardiovascular Complications, Kidney Disease And Death in People with Type 2 Diabetes     6/14/2016
Novo Nordisk A/S (NVO) Release: Victoza (Liraglutide) Significantly Reduced The Risk Of Major Cardiovascular Events And Death In Adults With Type 2 Diabetes In The LEADER Trial     6/14/2016
Novo Nordisk Canada Inc. (NVO) Release: Study Finds Victoza Significantly Reduced The Risk Of Heart Attack And Stroke In People With Type 2 Diabetes     6/14/2016
DexCom (DXCM) Release: Data Supports Continuous Glucose Monitoring (CGM) To Reduce Need For Self-Monitoring Of Blood Glucose For Type 1 Diabetes     6/14/2016
Novo Nordisk A/S (NVO) Release: Semaglutide Demonstrated Superior Improvements In Glycaemic Control Vs Sitagliptin (SUSTAIN 2) And Exenatide ER (SUSTAIN 3) In Two Clinical Trials In Adults With Type 2 Diabetes     6/13/2016
Dynavax (DVAX) Presents New Efficacy Data On Hepatitis B Vaccine, HEPLISAV-B, In Adults With Type 2 Diabetes At American Diabetes Association Scientific Sessions     6/13/2016
Poxel Presents New Data On Imeglimin’s Dual Mechanism Of Action At The American Diabetes Association’s 76th Scientific Sessions     6/13/2016
Eli Lilly (LLY) Release: New Study Results Show Tradjenta (Linagliptin) Reduces Blood Sugar In Adults With Type 2 Diabetes At Risk For Kidney Impairment     6/13/2016
Livongo Studies Demonstrate Latest Technology, Coaching, And Real-Time Data Improve Blood Glucose Control For People With Diabetes     6/13/2016